title: Analysis of endothelial protein C receptor gene and metabolic profile in Prader-Willi syndrome and obese subjects.
abstract: The endothelial protein C receptor (EPCR) has a critical role in the regulation of anticoagulant and anti-inflammatory functions of activated protein C (APC). Abnormalities in EPCR might be associated with an increased risk of thrombosis. In this respect, a 23 bp insertion in the exon 3 of the EPCR gene predicts a truncated protein which cannot bind APC. High levels of C-reactive protein (CRP), a strong predictor of cardiovascular events, are found both in the obese and in subjects with Prader-Willi syndrome (PWS). Several cardiovascular risk factors are already present in prepubertal PWS children, but it is uncertain which mechanism contributes to the increased risk of cardiovascular disease in PWS. We analyzed the distribution of 23 bp insertion in the EPCR gene in 81 overweight and obese PWS subjects, 52 adults and 29 children, and in 58 overweight and obese children and adolescents (controls). We found that 1/58 (1.7%) of the controls was heterozygous for the 23 bp insertion, while this mutation was never found in PWS subjects. Furthermore, we evaluated CRP levels, glucose, insulin, and lipid profile, and we found higher CRP values in PWS adults with respect to children with PWS and controls, and a better insulin sensitivity in all PWS subjects than in the controls. This study suggests that in PWS subjects there is no predisposition to develop thrombotic events in association with EPCR gene alteration and demonstrates substantial differences regarding metabolic and inflammatory profile between PWS and non-PWS obese children, with further impairment in adults with PWS.
authors.affiliation: Department of Biomedicine of Developmental Age, University of Bari, Bari, Italy. mf.faienza@endobiomol.uniba.it
authors.forename: Maria F
authors.initials: MF
authors.lastname: Faienza
authors.forename: Annamaria
authors.initials: A
authors.lastname: Ventura
authors.forename: Rosaria
authors.initials: R
authors.lastname: Lauciello
authors.forename: Antonino
authors.initials: A
authors.lastname: Crinò
authors.forename: Letizia
authors.initials: L
authors.lastname: Ragusa
authors.forename: Luciano
authors.initials: L
authors.lastname: Cavallo
authors.forename: Sabrina
authors.initials: S
authors.lastname: Spera
authors.forename: Graziano
authors.initials: G
authors.lastname: Grugni
mesh_terms: D000293:Adolescent; D000328:Adult; D015703:Antigens, CD / Q000235:genetics*; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism; D002648:Child; D000074283:Endothelial Protein C Receptor; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000235:genetics*; D008297:Male; D055442:Metabolome; D016254:Mutagenesis, Insertional; D009765:Obesity / Q000235:genetics / Q000378:metabolism*; D036361:Peptide Hormones / Q000235:genetics*; D011218:Prader-Willi Syndrome / Q000235:genetics / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000235:genetics*; D012307:Risk Factors; D013927:Thrombosis / Q000235:genetics
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D001786:Blood Glucose; D000074283:Endothelial Protein C Receptor; D007328:Insulin; C478370:PROCR protein, human; D036361:Peptide Hormones; D011956:Receptors, Cell Surface; C508331:exon 3-deleted preproghrelin, human; D002097:C-Reactive Protein